Frontier mental health research: psychedelics & drug studies

Key findings

• Ayahuasca is a plant brew that combines DMT with other plants that block the body from breaking DMT down, so it works when taken by mouth. ¹⁵⁰⁸²
• DMT and ayahuasca interact with serotonin-related brain receptors and can promote brain plasticity — meaning they can help nerve cells grow new branches and make new connections in lab and animal studies. ^{15050 15082 15059}
• Small clinical studies and some phase II trials report quick antidepressant effects after one or a few doses of DMT-containing treatments or ayahuasca, which is encouraging for treatment-resistant depression but still preliminary. ^{15082 15060 15063 15091}
• Many researchers say the way a session is run — preparation, the therapy given around the drug, the music, and feeling safe — strongly affects whether people improve, so benefits are not just the drug alone. ^{15092 15063 15091}
• A large review found no clear change in blood levels of brain-derived neurotrophic factor (BDNF) after psychoplastogen drugs in humans, so measuring blood BDNF has not been a reliable sign of brain change after these treatments. ¹⁵¹²⁹
• Trials so far are small and early-stage, and study samples often lack diversity; because of that, we do not yet know how well the results apply to all people or how long the effects last. ^{15085 15082 15095 15063}
• Safety signals are mixed: some clinical reports say treatments were generally tolerated in controlled settings, but related compounds (like high doses of ibogaine) have shown serious cardiac and neurological risks in past studies, and animal work shows dose- and sex-dependent differences — so careful medical oversight is important. ^{15063 15085 15050 15091}